MicroOptx Medical

The company has created and patented the first working nano fabricated shunt to treat glaucoma. Glaucoma is a $5.8 billion market in the U.S .alone.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Maple Grove, MN, US
  • Currency USD
  • Founded October 2014
  • Employees 4
  • Website microoptx.com

Company Summary

MicroOptx Medical leverages academic bioengineering, surgical expertise, micro engineering manufacturing and nano technology to provide the modern solution for the vexing problem of Glaucoma. The company is building upon $3.4 million already invested in the technology design and preliminary successful bench and animal studies. It is lead by recognized medical, industry and financial veterans who are dedicated towards preventing blindness.

Team

  • Roy Martin
    Chief Scientific Officer

    DVM
    30 year medical device veteran preclinical, clinical, reg and leadership
    16 US patents, CPI, Medtronic, Urologix, CVRx
    Partner- Integra investment and asset sale

  • David Brown
    Chief Medical Officer

    Highly respected ophthalmic surgeon
    30 years of glaucoma implant experience
    Inventor of the Brown Glaucoma Implant (BGI)

  • Chris Pulling
    Chief Executive Officer

    15 years experience Urologix, Medtronic, Founder- The Integra Group
    Self funded start-up to 73 employees and multimillion$ NAMSA asset sale

  • Keith Bares
    Director

    Managing Partner - Convergent Capital
    30 year private equity, wall street and VC leader
    Multiple company purchases and successful exits

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free